DK
Daphne Kaur Kandiala
About Daphne Kaur Kandiala
Data last updated:
Daphne Kaur Kandiala is a Managing Director at Dapcure Pharmaceutical Private Limited (since 2020) and Director at Mapsn Drug Private Limited (since 2020). The companies operate in Pharma and Healthcare. The largest current company by reported revenue is Dapcure Pharmaceutical Private Limited at ₹2.1 Lakh (FY 2022).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Managing Director | 14 Feb 2020 | 2020 | ₹2.1 Lakh (FY 2022) | Active | |
| Director | 01 Dec 2020 | 2020 | Active |
Board colleagues of Daphne Kaur Kandiala
| Name | DIN | Company | Designation |
|---|---|---|---|
| Sukhvinder Singh Kandiala | 08978640 | Dapcure Pharmaceutical Private Limited , Mapsn Drug Private Limited | Nominee |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Daphne Kaur Kandiala
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Daphne Kaur Kandiala
Daphne Kaur Kandiala currently holds 2 directorships: Dapcure Pharmaceutical Private Limited (Managing Director, since 14 Feb 2020, revenue ₹2.1 Lakh (FY 2022)); Mapsn Drug Private Limited (Director, since 01 Dec 2020).
Daphne Kaur Kandiala was first appointed on 14 Feb 2020 as Managing Director at Dapcure Pharmaceutical Private Limited.
The current boards of Daphne Kaur Kandiala's companies include Sukhvinder Singh Kandiala (Dapcure Pharmaceutical Private Limited).